These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 13528805)
1. [Notes on liver function test in mental patients treated with promazine]. PARDERA G Riv Patol Nerv Ment; 1957; 78(3):1106-8. PubMed ID: 13528805 [No Abstract] [Full Text] [Related]
2. [Notes on the function and morphology of the liver in patients treated with large doses of reserpine]. MENGHINI G; ORLANDI F; MANCINI P Minerva Med; 1958 Jun; 49(45):2241-3. PubMed ID: 13565644 [No Abstract] [Full Text] [Related]
3. Effects of promazine in mental syndromes. AZIMA H; DUROST H Can Med Assoc J; 1957 Mar; 76(6):442-6. PubMed ID: 13413759 [No Abstract] [Full Text] [Related]
4. Studies on the use of promazine in acute and chronic nervous and mental disturbances. BURDINE WE; SHIPLEY TE; PAPAS AT J Med Assoc Ga; 1957 Apr; 46(4):171-3. PubMed ID: 13416819 [No Abstract] [Full Text] [Related]
5. An evaluation of promazine hydrochloride in psychiatric practice. LESSE S Am J Psychiatry; 1957 May; 113(11):984-7. PubMed ID: 13411277 [No Abstract] [Full Text] [Related]
6. Promazine (sparine) in the treatment of psychiatric disorders. LEMERE F Northwest Med; 1956 Jul; 55(7):790-1. PubMed ID: 13348976 [No Abstract] [Full Text] [Related]
7. Studies of hepatic function in patients receiving promazine. KORN RJ; ROCK W; ZIMMERMAN HJ Am J Med Sci; 1958 Apr; 235(4):431-6. PubMed ID: 13520727 [No Abstract] [Full Text] [Related]
8. [Notes on the use of a new phenothiazine derivative, perphenazine, in neuro-psychiatric practice]. LARICCHIA R; BASEVI A Minerva Med; 1958 May; 49(39, Suppl.):1993-5. PubMed ID: 13565614 [No Abstract] [Full Text] [Related]
9. Treatment of psychiatric disorders in mental defectives with perphenazine. SPROGIS GR; BABCOCK SD; SEGALL J J Med Soc N J; 1958 Mar; 55(3):120-3. PubMed ID: 13514429 [No Abstract] [Full Text] [Related]
10. [On the results of using the Forrests' test on mental patients treated with aminazine and propazine]. Likhobabenko IuM Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(11):1701-6. PubMed ID: 6001062 [No Abstract] [Full Text] [Related]
11. Changes in the electroencephalogram caused by intravenous perphenazine in normal subjects and mental disease patients; preliminary note. NEGRI VU; BASEVI A Minerva Med; 1958 May; 49(39, Suppl.):1995-9. PubMed ID: 13565615 [No Abstract] [Full Text] [Related]
12. [Early results of therapeutic use of promazine in child neuropsychiatry]. VERGANI O; ALDEGHI E Minerva Pediatr; 1957 Apr; 9(17):467-70. PubMed ID: 13451445 [No Abstract] [Full Text] [Related]
13. Prochlorperazine in hospitalized and private psychiatric patients. WILCOX F Dis Nerv Syst; 1958 Mar; 19(3):118-21. PubMed ID: 13524118 [No Abstract] [Full Text] [Related]
14. Treatment of ambulatory and hospitalized psychiatric patients with trilafon. AYD FJ Dis Nerv Syst; 1957 Oct; 18(10):394-7. PubMed ID: 13473680 [No Abstract] [Full Text] [Related]
15. [Behavior of various liver function tests in patients undergoing largactil therapy: description of three cases of acute benign liver disease]. PELIZZARI G; PELLEGRINI G Rass Studi Psichiatr; 1954; 43(5):965-78. PubMed ID: 14357652 [No Abstract] [Full Text] [Related]
16. The neuroleptic action and effectiveness of proclorperazine in psychiatric disorders. FREYHAN FA Psychiatr Res Rep Am Psychiatr Assoc; 1958 Mar; 9():32-45. PubMed ID: 13567917 [No Abstract] [Full Text] [Related]
17. [Long-term treatment of mental disorders with high doses of phenothiazines]. van PAASSEN ; RONNER HJ Ned Tijdschr Geneeskd; 1959 Oct; 103():2201-3. PubMed ID: 14429630 [No Abstract] [Full Text] [Related]